Triomics
SAN FRANCISCO, California, United States · Information Technology
Triomics combines the most advanced clinical trial tracking software with a global network of supersites and partners to deliver rapid, cost-effective, high quality clinical trials that pass even the most rigorous regulatory scrutiny.
Key facts
- Headquarters
- SAN FRANCISCO, California, United States
- Employees
- Unknown
- Industries
- Information Technology
- Status
- Private
- Website
- triomics.in
- Company page
Recent activity at Triomics
Triomics funding history
| Date | Round | Amount |
|---|---|---|
| May 2026 | Series B | $22.0M |
| Feb 2023 | Venture | $13.8M |
Leadership
- Sarim Triomics, Co-founder & CEO
- Daniel, Medical Director; Founding Marketer
- Harsh Jain, Director of Market Intelligence
- Sameer Brij Verma, Director
- Devtosh Kumar Khare, Director
- Hrituraj Singh, Director
- Sajjan Rajpurohit, Director
- Sarim Khan, Executive Officer, Director
Verified email and direct lines for Triomics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Triomics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Triomics in the news
- Mission Bio Launches Tapestri® Triomics for Simultaneous DNA, RNA, and Protein Analysis at Single-Cell Resolution - Business Wire (Sep 16, 2026)
- MSK to Deploy Triomics’ AI Platform to Improve Clinical Trial Matching and Screening - Memorial Sloan Kettering Cancer Center (Nov 04, 2025)
- Triomics nabs $22M to bring oncology-specific AI to cancer centers - TechCrunch (May 27, 2026)
- Where participation in clinical trials for cancer lacks, Triomics could step in - Fierce Healthcare (May 10, 2024)
- Triomics Raises $22M to Scale Oncology AI for Early Cancer Detection and Treatment - HackerNoon (Jun 03, 2026)
- Triomics Revenue 2024: $9.9M Est. - GetLatka (Dec 08, 2024)
- A tri-omics and machine learning framework identifies prognostic biomarkers and metabolic signatures in sepsis - Nature (Jan 29, 2026)
- Triomics Automates Oncology Workflows With GenAI Powered Platform, Raises $15M - ACCESS Newswire (May 14, 2024)
Companies similar to Triomics
- FF EAI Robotics Ecosystem Inc. · Information Technology
- Intelligent Mapping, LLC · Information Technology
- Datavault AI · Information Technology
- IREN · Information Technology
- Omnissa · Information Technology
About Triomics: questions and answers
What does Triomics do?
Triomics combines the most advanced clinical trial tracking software with a global network of supersites and partners to deliver rapid, cost-effective, high quality clinical trials that pass even the most rigorous regulatory scrutiny.
Where is Triomics headquartered?
Triomics is headquartered in SAN FRANCISCO, California, United States.
Has Triomics raised funding?
Yes. Fundz has recorded 2 funding events for Triomics. The most recent, Series B of $22.0M, was in May 2026.
Who leads Triomics?
Sarim Triomics is a Co-founder & CEO at Triomics.
What is the latest news on Triomics?
On May 27, 2026, Triomics raises $22M in Series B funding led by Battery Ventures to enhance its oncology-specific AI platform.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy